Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | BMRN | ARWR | ||
| Company | Halozyme Therapeutic | Biomarin Pharmaceuticals | Arrowhead Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 105.84 | 65.00 | 82.87 | ||
| High | 109.27 | 66.80 | 85.47 | ||
| Low | 105.48 | 64.99 | 82.09 | ||
| Last | 109.11 | 66.36 | 83.29 | ||
| Change | +1.39 | +1.52 | +0.55 | ||
| Percent Change | +1.29% | +2.34% | +0.66% | ||
| Volume | 517,048 | 500,146 | 337,966 | ||
| 20-Day Average Volume | 2,308,625 | 2,241,837 | 1,026,276 | ||
| Previous | 107.72 | 64.84 | 82.74 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 104.28 | 66.52 | 86.88 | ||
| 20-Day Raw Stochastic | 97.76% | 62.03% | 22.70% | ||
| 20-Day Relative Strength | 72.36 | 57.32 | 47.60 | ||
| Weighted Alpha | +61.06 | +21.95 | +131.56 | ||
| Today's Opinion | 100% Buy | 80% Buy | 56% Buy | ||
| Yesterday's Opinion | 100% Buy | 80% Buy | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.86% since 08/26/26 | +1.19% since 08/26/26 | -6.79% since 08/26/26 | ||
| Low | 103.47 on 08/31/26 | 64.07 on 08/28/26 | 80.75 on 08/31/26 | ||
| High | 109.27 on 09/02/26 | 66.75 on 09/02/26 | 89.59 on 08/27/26 | ||
| 1-Month | |||||
| %Chg | +32.12% since 07/31/26 | +10.61% since 07/31/26 | -1.87% since 07/31/26 | ||
| Low | 81.75 on 08/04/26 | 58.89 on 08/06/26 | 80.75 on 08/31/26 | ||
| High | 109.66 on 08/26/26 | 70.98 on 08/12/26 | 90.97 on 08/11/26 | ||
| 3-Month | |||||
| %Chg | +64.54% since 06/02/26 | +24.51% since 06/02/26 | +17.30% since 06/02/26 | ||
| Low | 66.00 on 06/03/26 | 53.01 on 06/03/26 | 69.51 on 06/10/26 | ||
| High | 109.66 on 08/26/26 | 70.98 on 08/12/26 | 95.49 on 07/22/26 | ||
| 6-Month | |||||
| %Chg | +56.13% since 03/02/26 | +11.13% since 03/02/26 | +29.13% since 03/02/26 | ||
| Low | 61.33 on 03/27/26 | 49.26 on 05/18/26 | 54.02 on 03/13/26 | ||
| High | 109.66 on 08/26/26 | 70.98 on 08/12/26 | 95.49 on 07/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,226,005 | 12,551,338 | 11,654,508 | ||
| Shares Outstanding, K | 113,498 | 193,574 | 140,857 | ||
| Annual Sales, $M | 1,396,610,000 | 3,221,250,000 | 829,450,000 | ||
| Annual Net Income, $M | 316,890,000 | 348,900,000 | -1,630,000 | ||
| Last Qtr Sales, $M | 481,000,000 | 989,710,000 | 75,250,000 | ||
| Last Qtr Income, $M | 229,910,000 | 44,760,000 | -194,280,000 | ||
| 60-Month Beta | 0.88 | 0.24 | 1.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.28 on 08/06/26 | 1.20 on 08/06/26 | -1.36 on 08/04/26 | ||
| Latest Earnings Date | 11/02/26 | 10/26/26 | 11/24/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 21.60 | 38.83 | 0.00 | ||